Zydus Lifesciences (ZYDUSLIFE) — Financial Results

Zydus Lifesciences reported consolidated revenue of ₹65,737 crores for the half-year ended September 30, 2025. Net profit reached ₹14,668 crores with earnings per share of ₹14.58 (basic). The company demonstrated profitability across continuing operations, maintaining paid-up equity of ₹1,006 crores throughout the period.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this financial results affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 7 November 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 7 November 2025

TRENT Trent Limited Financial Results TRENT Trent Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.